Browsing Tag
Kodiak Sciences Inc.
1 post
Kodiak Sciences (NASDAQ: KOD) bets Phase 3 momentum and 2027 cash runway can turn pipeline promise into a retina franchise
Kodiak Sciences is chasing a retina comeback with Phase 3 Zenkuda data, a longer cash runway, and major catalysts ahead. Read what happens next.